1. Home
  2. CRIS vs NTWK Comparison

CRIS vs NTWK Comparison

Compare CRIS & NTWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRIS
  • NTWK
  • Stock Information
  • Founded
  • CRIS 2000
  • NTWK 1997
  • Country
  • CRIS United States
  • NTWK United States
  • Employees
  • CRIS N/A
  • NTWK N/A
  • Industry
  • CRIS Biotechnology: Biological Products (No Diagnostic Substances)
  • NTWK Computer Software: Prepackaged Software
  • Sector
  • CRIS Health Care
  • NTWK Technology
  • Exchange
  • CRIS Nasdaq
  • NTWK Nasdaq
  • Market Cap
  • CRIS 21.3M
  • NTWK 33.8M
  • IPO Year
  • CRIS 2000
  • NTWK 1998
  • Fundamental
  • Price
  • CRIS $1.81
  • NTWK $3.74
  • Analyst Decision
  • CRIS Strong Buy
  • NTWK
  • Analyst Count
  • CRIS 2
  • NTWK 0
  • Target Price
  • CRIS $16.50
  • NTWK N/A
  • AVG Volume (30 Days)
  • CRIS 163.8K
  • NTWK 26.0K
  • Earning Date
  • CRIS 07-31-2025
  • NTWK 05-14-2025
  • Dividend Yield
  • CRIS N/A
  • NTWK N/A
  • EPS Growth
  • CRIS N/A
  • NTWK N/A
  • EPS
  • CRIS N/A
  • NTWK 0.02
  • Revenue
  • CRIS $11,202,000.00
  • NTWK $64,127,568.00
  • Revenue This Year
  • CRIS N/A
  • NTWK N/A
  • Revenue Next Year
  • CRIS $10.67
  • NTWK N/A
  • P/E Ratio
  • CRIS N/A
  • NTWK $180.68
  • Revenue Growth
  • CRIS 14.17
  • NTWK 9.18
  • 52 Week Low
  • CRIS $1.02
  • NTWK $2.14
  • 52 Week High
  • CRIS $8.29
  • NTWK $3.94
  • Technical
  • Relative Strength Index (RSI)
  • CRIS 43.58
  • NTWK 86.95
  • Support Level
  • CRIS $1.50
  • NTWK $3.27
  • Resistance Level
  • CRIS $1.98
  • NTWK $3.77
  • Average True Range (ATR)
  • CRIS 0.19
  • NTWK 0.15
  • MACD
  • CRIS -0.05
  • NTWK 0.06
  • Stochastic Oscillator
  • CRIS 43.88
  • NTWK 87.50

About CRIS Curis Inc.

Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

About NTWK NetSol Technologies Inc. Common Stock

NETSOL Technologies Inc is involved in providing information technology and enterprise software solutions. Its products and services include NFS Ascent, NFS Digital, Leasepak Cloud, Business consultancy, and information security services among others. The firm has North America, Europe, and Asia-Pacific segments, of which the majority of the revenue is derived from Asia-Pacific. It derives revenue from licensing, customization, enhancements, and maintenance of its financial applications. The company promotes and sells its products under the Netsol financial suite.

Share on Social Networks: